Acd-a
FDA Label NDC 53157-796

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Haemonetics Manufacturing Inc for the product Acd-a (NDC 53157-796). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, indications and usage, contraindications, warnings, precautions, general, how supplied, package/label principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Description

Re-Order Product Code: 796-08

750 mL volume. Single use container.

Sterile, nonpyrogenic fluid path. Sterilized by steam.

Store at room temperature.

Indications And Usage

For use with automated pheresis equipment only. Use according to equipment manufacturer’s instructions. This unit should be used for pheresis only.

Contraindications

Not for direct intravenous infusion.

Warnings

Avoid excessive heat. Protect from freezing.

Precautions

Do not use unless solution is clear and no leaks detected.

General

Rx only. Discard unused portion.

Recommended Storage: Store at room temperature (25°C / 77°F).

How Supplied

750 mL volume bag.

Each 100 ml contains:

0.73 g citric acid (anhydrous), USP

2.20 g sodium citrate (dihydrate), USP

2.45 g dextrose (monohydrate), USP

Package/Label Principal Display Panel

Hot Stamped Bag

Envelope Label

References

HAEMONETICS and THE Blood Management Company are trademarks of Haemonetics Corporation.

Manufactured for:

Haemonetics Corporation

400 Wood Road

Braintree, MA 02184, USA

By: Haemonetics Manufacturing Inc.

1630 Industrial Park Street

Covina, CA 91722, USA

* Please review the disclaimer below.